TMO EPM / Hemato H9J

podcast

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julh...

Health & Fitness 88 recordings 2023 → today Every two weeks updated 4 days ago
Search in TMO EPM / Hemato H9J →

All episodes

61–80 of 88
28 - Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial contributed by Lukas · Apr 24, 2024
27 - Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma contributed by Lukas · Apr 14, 2024
26 - Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3 contributed by Lukas · Apr 6, 2024
25 - PTCy versus ATG after RIC peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors contributed by Lukas · Mar 28, 2024
24 - Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study contributed by Lukas · Mar 25, 2024
23 - Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up contributed by Lukas · Mar 16, 2024
22 - Tacrolimus /methotrexate vs tacrolimus / reduced-dose methotrexate / mycophenolate for graft-versus-host disease prevention contributed by Lukas · Mar 3, 2024
21 - Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids contributed by Lukas · Feb 29, 2024
20 - Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML contributed by Lukas · Feb 17, 2024
19 - Zanubrutinib Versus Ibrutinib in Symptomatic Waldenstrom Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study contributed by Lukas · Feb 4, 2024
18 - Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma contributed by Lukas · Jan 29, 2024
17 - Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease contributed by Lukas · Jan 14, 2024
16 - Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in AML contributed by Lukas · Dec 17, 2023
15 - Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation contributed by Lukas · Dec 3, 2023
14 - BuFlu vs BuCy for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial contributed by Lukas · Nov 26, 2023
13 - R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma contributed by Lukas · Nov 19, 2023
12 - PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation contributed by Lukas · Nov 13, 2023
11 - Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER) contributed by Lukas · Oct 22, 2023
10 - Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma contributed by Lukas · Oct 8, 2023
09 - Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft-versus-host disease prophylaxis contributed by Lukas · Oct 2, 2023
page 4 of 5 «« ← Prev Next → »»

Activity

module · podcast

7 episodes · last 30 days

Wed 6Sun 6Fri 4

Episodes per week over the last six months.

About

module · podcast

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

TMO EPM / Hemato H9J podcasters.spotify.com/pod/show/vin355cius-campos-de-moll RSS Apple